P&G Hygiene Profit Up 10.3% in Q2, Reaches Rs 229 Cr
Jan 31, 2024 14:16
Procter & Gamble Hygiene and Health Care Ltd reported a 10.32% rise in profit after tax to Rs 228.90 crore in Q2 FY24, driven by productivity and moderating cost inflation.
New Delhi, Jan 31 (PTI) Procter & Gamble Hygiene and Health Care Ltd on Wednesday reported a growth of 10.32 per cent in profit after tax at Rs 228.90 crore in the second quarter ended December, 2023 largely led by productivity, and moderating cost inflation.
The company, which follows the July-June financial year, had reported a profit after tax of Rs 207.47 crore in the corresponding quarter of the previous fiscal.
Procter & Gamble Hygiene and Health Care Ltd (PGHH) revenue from operations was marginally down to Rs 1,133.43 crore during the quarter under review. It was at Rs 1,137.39 crore a year ago.
"The profit growth is led by product price-mix, productivity, and moderating cost inflation versus the base period," the earning statement from the company which owns popular brands such as Vicks in healthcare and Whisper in feminine care said.
PGHH's total expense was at Rs 840.50 crore in the December quarter, down 2.85 per cent compared to the same period a year ago.
"The quarter has remained challenging amidst a difficult operating environment.
"We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority across product performance, packaging, brand communication, retail execution and consumer and customer value productivity, constructive disruption, and an agile and accountable organization," PGHH Managing Director LV Vaidyanathan said.
PGHH board has also declared an interim dividend of Rs 160 per equity share of face value of Rs 10 each for the financial year 2023-24.
"The company is celebrating its 60th year since the commencement of operation. This interim dividend includes a one-time special dividend of Rs 60 per equity share to commemorate this special occasion," it said.
The board of the company has also approved the appointment of Ashima Goyal as independent director of the company, for a period of five years.
Shares of Procter & Gamble Hygiene and Health Care Ltd on Wednesday were trading at Rs 17,149.95 on BSE, down 0.09 per cent from the previous close.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
DRI Seizes Red Sanders Worth Rs 6.26 Cr, 4...
DRI seizes 15 MT of red sanders worth Rs 6.26 crore in Delhi, arrests 4. Illegal export...
UAE Fund to Invest ₹1,000 Cr in Kerala Startups
UAE-based Feeder Fund to invest ₹1,000 crore in Kerala startups over 3 years. Boost...
ECL Aims for 58 MT Output, Mine Closures Planned
Eastern Coalfields Ltd (ECL) targets 58 MT output, plans closure of six underground...
India: Export Potential in Russia
300 Indian products have huge export potential in Russia. Engineering, pharma, agri,...
Gold & Silver Rally: Inflation Data in Focus
Gold and silver prices rally amid inflation data focus. Analysts eye central bank...
India Ranks 3rd in Global AI Vibrancy Index
India ranks 3rd in Stanford University's Global AI Vibrancy tool, surpassing advanced...
EPFOA Urges CPFC: Equip Offices for Compliance
EPFOA urges CPFC to equip field offices with authority & tools to handle default &...
TV Prices to Rise in January: Chip Shortage &...
TV prices are expected to increase in January due to memory chip shortages and a...
India Gems & Jewellery Exports Up 20% in November
India's gems and jewellery exports grew 20% to USD 2.5 billion in November, says GJEPC....
Navi Mumbai Airport: 3rd Runway Feasibility Study
CIDCO invites bids for a consultant to study the feasibility of a third runway at Navi...
Read More »